Menzaghi Frederique Ph.d. - Net Worth and Insider Trading
Menzaghi Frederique Ph.d. Net Worth
The estimated net worth of Menzaghi Frederique Ph.d. is at least $69,171 dollars as of 2024-12-27. Menzaghi Frederique Ph.d. is the Chief Scientific Off,SVP-R&D of Cara Therapeutics Inc and owns about 153,747 shares of Cara Therapeutics Inc (CARA) stock worth over $69,171. Details can be seen in Menzaghi Frederique Ph.d.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Menzaghi Frederique Ph.d. has not made any transactions after 2023-06-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Menzaghi Frederique Ph.d.
Menzaghi Frederique Ph.d. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Menzaghi Frederique Ph.d. owns 1 companies in total, including Cara Therapeutics Inc (CARA) .
Click here to see the complete history of Menzaghi Frederique Ph.d.’s form 4 insider trades.
Insider Ownership Summary of Menzaghi Frederique Ph.d.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2023-06-23 | VP-Research & Development |
Menzaghi Frederique Ph.d. Latest Holdings Summary
Menzaghi Frederique Ph.d. currently owns a total of 1 stock. Menzaghi Frederique Ph.d. owns 153,747 shares of Cara Therapeutics Inc (CARA) as of June 23, 2023, with a value of $69,171.
Latest Holdings of Menzaghi Frederique Ph.d.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2023-06-23 | 153,747 | 0.45 | 69,171 |
Holding Weightings of Menzaghi Frederique Ph.d.
Menzaghi Frederique Ph.d. Form 4 Trading Tracker
According to the SEC Form 4 filings, Menzaghi Frederique Ph.d. has made a total of 11 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 2,993 shares on June 23, 2023, which brought Menzaghi Frederique Ph.d. around $10,505.
Insider Trading History of Menzaghi Frederique Ph.d.
- 1
Menzaghi Frederique Ph.d. Trading Performance
Menzaghi Frederique Ph.d. Ownership Network
Menzaghi Frederique Ph.d. Owned Company Details
What does Cara Therapeutics Inc do?
Who are the key executives at Cara Therapeutics Inc?
Menzaghi Frederique Ph.d. is the VP-Research & Development of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and Chief Financial Officer Ryan D Maynard .
Cara Therapeutics Inc (CARA) Insider Trades Summary
Over the past 18 months, Menzaghi Frederique Ph.d. made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 60,412 shares made by Christopher Posner , a net sale of 2,753 shares made by Scott Terrillion , and a net sale of 2,753 shares made by Joana Goncalves .
In summary, during the past 3 months, insiders sold 3,668 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 3,668 shares. During the past 18 months, 65,918 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,918 shares.
Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cara Therapeutics Inc Insider Transactions
Menzaghi Frederique Ph.d. Mailing Address
Above is the net worth, insider trading, and ownership report for Menzaghi Frederique Ph.d.. You might contact Menzaghi Frederique Ph.d. via mailing address: C/o Cara Therapeutics, Inc., 1 Parrott Drive, Shelton Ct 06484.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
